Fear of Cancer Recurrence in Genitourinary Cancer

To perform an analysis of independent predictors of fear of cancer recurrence in patients with malignant genitourinary diseases and their impact on quality of life and survival

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fear of Cancer Recurrence Adenocarcinoma Carcinoma Carcinoma, Renal Cell Carcinoma, Transitional Cell Endocrine Gland Neoplasms Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Gonadal Disorders Kidney Diseases Kidney Neoplasms Male Urogenital Diseases Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Prostate Cancer Prostatic Diseases Prostatic Neoplasms Renal Cell Cancer Testicle Cancer Testicular Diseases Testicular Neoplasms Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms Urothelial Carcinoma

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ludwig-Maximilian-Universität

Munich, Bavaria, 80796, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

histologically confirmed diagnosis of either prostate, urothelial cell, testicular or renal cell cancer

Treatment and study plan

FCR7 questionnaire

Other

A 7 item questionnaire about fear of cancer recurrence

Primary outcomes

Changes in fear of cancer recurrence pre- and postoperatively

Time frame: 7 to 10 days after initial surgery

Changes in the FCR7 score pre- and postoperatively

Sponsors and collaborators

Lead sponsor

Ludwig-Maximilians - University of Munich

Other

Registry information

Official study title

Fear of Cancer Recurrence in Malignant Diseases of the Genitourinary Tract

Important dates

Study start: 2019
Primary completion: 2021
Study completion: 2022
First posted: Sep 2, 2020
Registry last updated: Dec 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting